Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 4,658 | 30,605 | 61 | 513 | 1,135 |
| Gross Profit | 4,658 | 30,605 | 61 | 513 | 1,135 |
| Operating Expenses | 80,821 | 77,197 | 65,727 | 72,416 | 68,126 |
| Operating Income | -76,163 | -46,592 | -65,666 | -71,903 | -66,991 |
| Interest Expense | 2,216 | 2,195 | 0 | 1 | -6 |
| Other Income | 2,291 | 3,392 | 3,525 | 4,297 | 5,035 |
| Pre-tax Income | -76,088 | -45,395 | -62,141 | -67,607 | -61,950 |
| Net Income Continuous | -76,088 | -45,395 | -62,141 | -67,607 | -61,950 |
| Net Income | $-76,088 | $-45,395 | $-62,141 | $-67,607 | $-61,950 |
| EPS Basic Total Ops | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| EPS Basic Continuous Ops | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| EPS Diluted Total Ops | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| EPS Diluted Continuous Ops | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.55 | -0.75 | N/A | N/A |
| EBITDA(a) | $-74,829 | $-46,080 | $-65,393 | $-72,363 | $-67,298 |